PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases
出版年份 2019 全文链接
标题
PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases
作者
关键词
-
出版物
Alzheimers Research & Therapy
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-12-07
DOI
10.1186/s13195-019-0561-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Amyloid-β Load Is Related to Worries, but Not to Severity of Cognitive Complaints in Individuals With Subjective Cognitive Decline: The SCIENCe Project
- (2019) Sander C. J. Verfaillie et al. Frontiers in Aging Neuroscience
- Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
- (2019) Arno de Wilde et al. Alzheimers Research & Therapy
- Upward drift in cerebrospinal fluid amyloid β 42 assay values for more than 10 years
- (2018) Suzanne E. Schindler et al. Alzheimers & Dementia
- Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
- (2018) Niklas Mattsson et al. Alzheimers & Dementia
- The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review
- (2018) Oskar Hansson et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Amsterdam Dementia Cohort: Performing Research to Optimize Care
- (2018) Wiesje M. van der Flier et al. JOURNAL OF ALZHEIMERS DISEASE
- Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort
- (2018) Arno de Wilde et al. JAMA Neurology
- Longitudinal Changes of CSF Biomarkers in Alzheimer's Disease
- (2018) Toni T. Seppälä et al. JOURNAL OF ALZHEIMERS DISEASE
- Optimizing Patient Care and Research: The Amsterdam Dementia Cohort
- (2018) Wiesje M. van der Flier et al. JOURNAL OF ALZHEIMERS DISEASE
- MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study
- (2018) Mara ten Kate et al. Alzheimers Research & Therapy
- The Cerebrospinal Fluid Aβ1–42/Aβ1–40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer’s Disease in a Clinical Setting
- (2017) Ellis Niemantsverdriet et al. JOURNAL OF ALZHEIMERS DISEASE
- Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes
- (2017) Wei Qiang et al. NATURE
- Differential effects of cognitive reserve and brain reserve on cognition in Alzheimer disease
- (2017) Colin Groot et al. NEUROLOGY
- Diagnostic impact of [18F]flutemetamol PET in early-onset dementia
- (2017) Marissa D. Zwan et al. Alzheimers Research & Therapy
- Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
- (2016) Sebastian Palmqvist et al. BRAIN
- Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer’s Disease
- (2016) Piotr Lewczuk et al. JOURNAL OF ALZHEIMERS DISEASE
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
- (2015) Osama Sabri et al. Alzheimers & Dementia
- What does it mean to be ‘amyloid-positive’?
- (2015) Anne M. Fagan BRAIN
- Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
- (2015) Willemijn J. Jansen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Amyloid biomarkers in Alzheimer's disease
- (2015) Kaj Blennow et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density
- (2015) Craig Curtis et al. JAMA Neurology
- mice: Multivariate Imputation by Chained Equations inR
- (2015) Stef van Buuren et al. Journal of Statistical Software
- A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
- (2014) Frank Jessen et al. Alzheimers & Dementia
- Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease
- (2014) Niklas Mattsson et al. BRAIN
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
- (2014) Kristin R Wildsmith et al. Molecular Neurodegeneration
- Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions
- (2014) R. Ossenkoppele et al. NEUROLOGY
- Variability of CSF Alzheimer’s Disease Biomarkers: Implications for Clinical Practice
- (2014) Stephanie J. B. Vos et al. PLoS One
- Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease
- (2014) A. M. Fagan et al. Science Translational Medicine
- Longitudinal Amyloid Imaging Using 11C-PiB: Methodologic Considerations
- (2013) B. N. M. van Berckel et al. JOURNAL OF NUCLEAR MEDICINE
- Biomarker Modeling of Alzheimer’s Disease
- (2013) Clifford R. Jack et al. NEURON
- Impact of molecular imaging on the diagnostic process in a memory clinic
- (2012) Rik Ossenkoppele et al. Alzheimers & Dementia
- Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET
- (2012) Rik Ossenkoppele et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
- (2012) Christopher M Clark et al. LANCET NEUROLOGY
- Indicators of amyloid burden in a population-based study of cognitively normal elderly
- (2012) M. M. Mielke et al. NEUROLOGY
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Visual assessment of posterior atrophy development of a MRI rating scale
- (2011) Esther L. G. E. Koedam et al. EUROPEAN RADIOLOGY
- Classification of primary progressive aphasia and its variants
- (2011) M. L. Gorno-Tempini et al. NEUROLOGY
- Absence of Pittsburgh Compound B Detection of Cerebral Amyloid β in a Patient With Clinical, Cognitive, and Cerebrospinal Fluid Markers of Alzheimer Disease
- (2009) Nigel J. Cairns et al. ARCHIVES OF NEUROLOGY
- Cerebrospinal fluid tau and ptau181increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
- (2009) Anne M. Fagan et al. EMBO Molecular Medicine
- Fibrillar amyloid- burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
- (2009) E. M. Reiman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Conditional Variable Importance for Random Forests
- (2008) Carolin Strobl et al. BMC BIOINFORMATICS
- Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
- (2008) Milos D. Ikonomovic et al. BRAIN
- Second consensus statement on the diagnosis of multiple system atrophy
- (2008) S. Gilman et al. NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started